Evidence map›Paper›PMID 32774788›Full record

ReviewComputational and structural biotechnology journal2020

POT1-TPP1 telomere length regulation and disease.

Tomas Aramburu, Sarah Plucinsky, Emmanuel Skordalakes

Open access · goldAbstract readReview
In one paragraph

Review in Computational and structural biotechnology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Whole exome sequencing identified two novel mutations ofFrontiers in cell and developmental biology · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. GermlineGenes · 2024
    Review
  18. Article
  19. The Altered Functions of Shelterin Components in ALT Cells.International journal of molecular sciences · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tomas AramburuThe Wistar Institute, 3601 Spruce St, Philadelphia, PA 19104, USA.
Sarah PlucinskyThe Wistar Institute, 3601 Spruce St, Philadelphia, PA 19104, USA.
Emmanuel SkordalakesThe Wistar Institute, 3601 Spruce St, Philadelphia, PA 19104, USA.
The Wistar Institute · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
NCI NIH HHS P30 CA010815
6 · The paper itself

Abstract

Telomeres are DNA repeats at the ends of linear chromosomes and are replicated by telomerase, a ribonucleoprotein reverse transcriptase. Telomere length regulation and chromosome end capping are essential for genome stability and are mediated primarily by the shelterin and CST complexes. POT1-TPP1, a subunit of shelterin, binds the telomeric overhang, suppresses ATR-dependent DNA damage response, and recruits telomerase to telomeres for DNA replication. POT1 localization to telomeres and chromosome end protection requires its interaction with TPP1. Therefore, the POT1-TPP1 complex is critical to telomere maintenance and full telomerase processivity. The aim of this mini-review is to summarize recent POT1-TPP1 structural studies and discuss how the complex contributes to telomere length regulation. In addition, we review how disruption of POT1-TPP1 function leads to human disease.

Indexed as

ATM, Ataxia Telangiectasia Mutated proteinATR, Ataxia Telangiectasia and Rad3-related ProteinCST, CTC1, Stn1 and Ten1CTC1, Conserved Telomere Capping Protein 1POT1POT1, Protection of telomere 1RAP1, Repressor/Activator Protein 1RPA, Replication Protein AShelterinSMCHD1, Structural Maintenance Of Chromosomes Flexible Hinge Domain Containing 1Stn1, Suppressor of Cdc ThirteenTelomeraseTelomeresTen1, Telomere Length Regulation ProteinTERC, Telomerase RNATERT, Telomerase Reverse TranscriptaseTIN2, TRF1- and TRF2-Interacting Nuclear Protein 2TPP1TPP1 also known as ACD, Adrenocortical Dysplasia Protein HomologTRF1, Telomere Repeat binding Factor 1TRF2, Telomere Repeat binding Factor 2TSPYL5, Testis-specific Y-encoded-like protein 5USP7, ubiquitin-specific-processing protease 7

Identifiers

PMID32774788
PMCPMC7385035
OpenAlexW3038684839

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.